Michela Sorensen on Balancing General Practice with Medical Consulting
MAR 11, 2024
Description Community
About

In this episode of CCIM, host Elise Putt sits down with Dr Michela Sorensen, a Sydney-based GP who has diversified her medical career into various other roles. Michela works part-time in general practice in the eastern suburbs of Sydney and also serves as a medical consultant for Warner Brothers and other tech companies. Additionally, she has made appearances as a media commentator on print, TV, and podcasts, leveraging her medical expertise to communicate health information in an easily understandable manner to the general public.

Michela shares her journey into medicine, discussing her early interest in medicine despite a non-medical background and revealing how she ultimately decided to pursue general practice after exploring various medical specialties. She provides insights into how she found herself involved in media and consulting work, highlighting the serendipitous nature of some of these opportunities and how she balances her multifaceted career.

Despite her varied professional pursuits, Michela emphasises that her passion for seeing patients and practising as a GP remains a crucial aspect of her career. She discusses her approach to balancing her clinical work with her media and consulting commitments, embracing the diverse nature of her career and the energising effect of engaging with different roles.

When asked about her dream career in an alternate universe, Dr. Sorensen expresses an interest in the fashion industry, citing her passion for fashion design as a potential alternate career path.

To get more CCIM, subscribe so you never miss an episode, join our Facebook community and subscribe to our newsletter!

Creative Careers in Medicine


CCIM on Facebook


The CCIM Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at Talking HealthTech

Comments